Anti-MUC2/ MLP/ MUC-2 monoclonal antibody

Anti-MUC2/ MLP/ MUC-2 antibody for FACS & in-vivo assay

Target products collectionGo to MUC2/MUC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2605-Ab-1/ GM-Tg-hg-MP2605-Ab-2Anti-Human MUC2 monoclonal antibodyHuman
GM-Tg-rg-MP2605-Ab-1/ GM-Tg-rg-MP2605-Ab-2Anti-Rat MUC2 monoclonal antibodyRat
GM-Tg-mg-MP2605-Ab-1/ GM-Tg-mg-MP2605-Ab-2Anti-Mouse MUC2 monoclonal antibodyMouse
GM-Tg-cynog-MP2605-Ab-1/ GM-Tg-cynog-MP2605-Ab-2Anti-Cynomolgus/ Rhesus macaque MUC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2605-Ab-1/ GM-Tg-felg-MP2605-Ab-2Anti-Feline MUC2 monoclonal antibodyFeline
GM-Tg-cang-MP2605-Ab-1/ GM-Tg-cang-MP2605-Ab-2Anti-Canine MUC2 monoclonal antibodyCanine
GM-Tg-bovg-MP2605-Ab-1/ GM-Tg-bovg-MP2605-Ab-2Anti-Bovine MUC2 monoclonal antibodyBovine
GM-Tg-equg-MP2605-Ab-1/ GM-Tg-equg-MP2605-Ab-2Anti-Equine MUC2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2605-Ab-1/ GM-Tg-hg-MP2605-Ab-2; GM-Tg-rg-MP2605-Ab-1/ GM-Tg-rg-MP2605-Ab-2;
GM-Tg-mg-MP2605-Ab-1/ GM-Tg-mg-MP2605-Ab-2; GM-Tg-cynog-MP2605-Ab-1/ GM-Tg-cynog-MP2605-Ab-2;
GM-Tg-felg-MP2605-Ab-1/ GM-Tg-felg-MP2605-Ab-2; GM-Tg-cang-MP2605-Ab-1/ GM-Tg-cang-MP2605-Ab-2;
GM-Tg-bovg-MP2605-Ab-1/ GM-Tg-bovg-MP2605-Ab-2; GM-Tg-equg-MP2605-Ab-1/ GM-Tg-equg-MP2605-Ab-2
Products NameAnti-MUC2 monoclonal antibody
Formatmab
Target NameMUC2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MUC2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species MUC2/ MLP/ MUC-2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2605
    Target NameMUC2
    Gene ID4583,17831,24572,720903,119864303,101096605,789571
    Gene Symbol and Synonyms2010015E03Rik,AABR07006030.1,HH-Muc,MCM,MLP,MUC-2,MUC2,mucin-2,SMUC,wnn
    Uniprot AccessionQ02817,P98089,Q62635
    Uniprot Entry NameMUC2_HUMAN,MUC2L_RAT,MUC2_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000198788
    Target ClassificationTumor-associated antigen (TAA)

    The target: MUC2, gene name: MUC2, also named as MLP, MUC-2, SMUC. This gene encodes a member of the mucin protein family. Mucins are high molecular weight glycoproteins produced by many epithelial tissues. The protein encoded by this gene is secreted and forms an insoluble mucous barrier that protects the gut lumen. The protein polymerizes into a gel of which 80% is composed of oligosaccharide side chains by weight. The protein features a central domain containing tandem repeats rich in threonine and proline that varies between 50 and 115 copies in different individuals. Downregulation of this gene has been observed in patients with Crohn disease and ulcerative colitis. [provided by RefSeq, Oct 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.